Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shanghai Pharmaceutical To Focus Fully On Drug Distribution

This article was originally published in PharmAsia News

Executive Summary

Shanghai Pharmaceutical Co., Ltd. has announced that it will withdraw from drug R&D and concentrate its resources on drug distribution, a business it has been leading domestically for nine years. The company will transfer its 19.66 percent stake in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical and inject 6.5 million yuan to its holding company Shanghai Waigaoqiao Pharmaceutical Business And Distribution Center. However, Shanghai Pharmaceutical will not give up its original equipment manufacturing business, which gives a return on investment of 27.5 percent. It will renovate Tianping Pharmaceutical Factory's machining workshop to carry out OEM for U.S. Perrigo. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068192

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel